Takeda Pharmaceuticals North America Bolsters Physician Training with Knowledge Factor’s Confidence-Based Learning System

Not what you were looking for? Continue your search here...

Denver, CO (PRWeb) February 15, 2007 -- Knowledge Factor, Inc., the leader in Confidence-Based Learning (CBL), today announced that it has been selected by Takeda Pharmaceuticals North America, a wholly owned subsidiary of Takeda Pharmaceuticals Company Limited, to build a performance improvement program for the international network of medical professionals who are certified experts in Takeda’s new insomnia medication Rozerem™. Using Knowledge Factor’s CBL System™, Takeda’s Sleep Consultant Network (SCN) will be able to validate that the members of the SCN have full mastery of all product knowledge and the relevant science around it, and that they are competent to represent the new drug to fellow physicians.

“Speakers whose purpose is to educate clinicians on the science of sleep and the medications Takeda provides must have a complete and verifiable understanding of our products in order to be accountable and effective,” said Paul Boidy, Senior Product Manager of Takeda Pharmaceuticals North America. “SCN Connect: The Mastery Program, which we are delivering using Knowledge Factor’s Confidence-Based Learning System, empowers us to certify that everyone in our network accurately masters the material and has the confidence required to represent it authoritatively. It brings us to a whole new level of confidence in the messaging and marketing of this new product.”

Takeda Pharmaceuticals Company Limited is the largest pharmaceutical company in Japan. Takeda developed the SCN to serve as a professional speakers bureau that educates the medical community about Rozerem and about important research surrounding sleep. Takeda chose CBL because of its unique ability to quickly identify knowledge and confidence gaps among physicians – even confident ones – and fix these gaps immediately through an accelerated learning process.

”The competing objectives of physicians, who want to learn quickly, and Takeda, which wants to ensure mastery, are perfectly served with this approach,” said Mark Dreher, CEO of Knowledge Factor. “The CBL process will provide physicians in the Network with a quick and efficient way of mastering the material, while giving Takeda the confidence of knowing their Network is fully educated on its product.”

Knowledge Factor, Inc.
Founded in 2000, Knowledge Factor has gained national acclaim for its unique ability to take learners in corporate or educational settings to a state of total mastery – confidently-held, correct knowledge put into practice. Knowledge Factor is the leader in Confidence-Based Learning and owner of a patented process that measures and fixes both knowledge and confidence gaps among employees. The Company's CBL System™ measures competency, validates learning and provides rapid and targeted learning solutions to organizations and individuals that need to achieve mastery. For more information, go to www.knowledgefactor.com.
Takeda Pharmaceuticals North America, Inc.

Based in Lincolnshire, Ill., Takeda Pharmaceuticals North America, Inc. is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. In the United States, Takeda currently markets oral diabetes, insomnia, cholesterol-lowering and gastroenterology treatments, and has a robust pipeline with compounds in development for diabetes, cardiovascular disease and other conditions. Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. To learn more about the company and its products, visit www.tpna.com.

Contact
Alicia Hassinger
303.433.7020

# # #